Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GW642444 Inhalation Powder; Drug: FF/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Asthma; Pulmonary Disease, Chronic Obstructive
Intervention: Other: Empty inhalers
Sponsor: Orion Corporation, Orion Pharma
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium 18mcg daily; Drug: Salmeterol 100mcg daily; Drug: Fluticasone 250mcg daily; Drug: Fluticasone 125mcg daily; Drug: Fluticasone 50mcg daily; Drug: Placebo
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Dasatinib (Sprycel)
Sponsors: European Group for Blood and Marrow Transplantation; Bristol-Myers Squibb
Recruiting - verified March 2010